Research We Fund
Upstage Lung Cancer is proud to have funded over $1 million in lung cancer research.
2017-2018: Early Detection
This grant was funded in part by Upstage Lung Cancer
Geoffrey Oxnard, MD
Dana-Farber Cancer Institute/Harvard Medical School
Dr. Oxnard’s research studies noninvasive detection of plasma cell free DNA circulating in the blood, as a tool for detecting cancer-derived mutations. This transformative technology offers an opportunity to find targetable mutations, monitor for drug resistance, and even to detect subclinical metastatic disease. With a multi-pronged research approach, Dr. Oxnard aims to integrate plasma genotyping lung cancer care as a new diagnostic modality.